Key statistics
As of last trade Karyopharm Therapeutics Inc (25K:FRA) traded at 0.642, 6.29% above its 52-week low of 0.604, set on Nov 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.642 |
---|---|
High | 0.642 |
Low | 0.642 |
Bid | 0.6414 |
Offer | 0.6672 |
Previous close | 0.6596 |
Average volume | 350.00 |
---|---|
Shares outstanding | 124.68m |
Free float | 112.71m |
P/E (TTM) | -- |
Market cap | 92.15m USD |
EPS (TTM) | -0.8356 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:42 BST.
More ▼
Press releases
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm to Participate at Upcoming Investor Conferences
- Karyopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
- Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024